Using MRI to improve antibody treatment for early Alzheimer's
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether using a stronger MRI scanner can help make antibody treatments for early Alzheimer's disease work better. If you are already eligible for and starting such a treatment, this study may help track how well it's working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 90 years old.
- You have early Alzheimer's disease, meaning mild cognitive impairment or mild dementia.
- Your doctor has confirmed you have amyloid plaques in the brain (via spinal tap or PET scan).
- You are planning to start an anti-amyloid antibody treatment like lecanemab or donanemab.
- You are not currently taking blood thinners like warfarin or apixaban.
- You do not have other serious brain conditions (like Parkinson's disease or epilepsy) or a history of multiple strokes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a monoclonal antibody drug can help people with early Alzheimer's disease or mild cognitive impairment. The drug targets amyloid plaques in the brain, which are detected using a special PET scan before treatment.
This study tests antibody treatments that target amyloid plaques in the brain for people with mild memory or thinking problems. It may help determine if you are a candidate for these new drugs and monitors your safety through regular scans and checkups.
This trial tests a vaccine that may help the immune system clear a protein linked to Alzheimer's disease. It is for people who do not have memory problems yet but have signs of the disease in their blood or brain scans.
This trial studies how the brain removes amyloid-β, a protein linked to Alzheimer’s disease. It may help researchers understand what’s happening in people with mild memory impairment or Alzheimer’s, and guide better treatments in the future.
This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.
This study enrolls people with no memory impairment, mild memory problems, or mild Alzheimer’s dementia to test how brain scans and cognitive tests relate to Alzheimer’s disease. It may help by contributing to better early diagnosis and by letting you see whether you fit into the study’s imaging and blood-test pathway.
Hear when a new Alzheimer Dementia (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.